Actively Recruiting

Phase Not Applicable
Age: 50Years - 80Years
All Genders
NCT06702696

Effect of Aronia Berry Consumption on Inflammatory Parameters

Led by Amasya University · Updated on 2025-10-01

50

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The study will aim to evaluate the effects of consuming freeze-dried aronia berries as an adjunct to medical treatment in patients with chronic obstructive pulmonary disease (COPD), focusing on anti-inflammatory, respiratory, and biochemical parameters. It will be conducted at a research hospital in Istanbul, involving 50 participants aged 50-80 diagnosed with COPD. Participants will be randomly assigned to two groups: the aronia group (AG, n=25) and the placebo group (PG, n=25). The AG will receive 30 g of freeze-dried aronia powder daily, while the PG will receive 30 g of placebo powder, both for a duration of 8 weeks. Baseline demographic data will be collected through face-to-face interviews, while biochemical, respiratory, anthropometric, and body composition parameters will be assessed both before and after the intervention. Dietary intake records will also be collected and analyzed.

CONDITIONS

Official Title

Effect of Aronia Berry Consumption on Inflammatory Parameters

Who Can Participate

Age: 50Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged 50-80 years
  • Diagnosed with COPD
  • Not following a vegetarian or vegan diet
  • Willing to consume the provided aronia berry (black chokeberry)
  • Non-smokers
  • Have signed the informed consent form
  • Has not undergone endobronchial tube or valve surgery in the last two years.
Not Eligible

You will not qualify if you...

  • Presence of associated chronic inflammatory or rheumatic diseases
  • Chronic infections that may create a prothrombotic state
  • Chronic kidney disease (CKD)
  • Malignancy
  • Hereditary thrombophilia
  • Essential thrombocythemia
  • Diagnosed endocrine disorders
  • Malabsorption disorders
  • Allergy to any food or berry fruits
  • Smoking
  • Participants who did not sign the informed consent form

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Yedikule Göğüs Hastalıkları Hastanesi

Istanbul, Zeytinburnu, Turkey (Türkiye), 34020

Actively Recruiting

Loading map...

Research Team

B

Buse Sarıkaya, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here